Emerging Talents in: Comparative Immunology 2025/2026

Here we present the Frontiers in Immunology ‘Emerging Talents in: Comparative Immunology 2025/2026'. A series dedicated to highlighting the emerging talent of student researchers within the field of Comparative Immunology.



Across the world students are undertaking key research as part of their education in Comparative Immunology, however, most of this research is not communicated to the wider audience. We recognise that this is because many student researchers find the thought of peer-review daunting. At Frontiers, peer-review is considered a collaborative process and our interactive peer-review is tailored to provide hands-on guidance and constructive feedback to researchers. Our Topic Editors are committed to the development of emerging talents and want to see student researchers strive for success at publications.



The research presented here highlights the quality and diversity of student researchers across the field of Comparative Immunology. We welcome contributions in the form of original research, review, mini review, case report, hypothesis and theory, perspective, both experimental and computational studies that cover, but are not limited to, following themes:

1. Evolution of the Immune System Across Taxa

2. Comparative Mucosal Immunity and Host-Microbe Interactions

3. Immune Adaptations to Extreme Environments and Life History Strategies

4. Translational and Applied Comparative Immunology

5. Comparative Vaccinology in the Development of New Strategies for Vaccines to Control Infectious Diseases

6. Innovative Non-Vaccine-Based Strategies for Infectious Disease Control

- Including, but not limited to, bacteriophages, passive immunotherapy systems, natural immune-stimulants, and other emerging principles—particularly for taxa where vaccine efficacy is variable.



This Research Topic will help to identify emerging leaders and allow the community to follow the aspiring careers of our emerging, talented researchers. #EmergingTalentsInComparative Immunology



Please note: To be considered for this collection, the first and/or collaborating first, or second author will be a registered undergraduate or graduate student at time of submission.



Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in the mission statement. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Dr. Marco Rozas-Serri declares that he is the founder and CEO of the Private Company Pathovet Labs; The other Topic Editors declare no competing interests with regard to the Research Topic subject.